No Detail Found!

Correlation of Genes And Risk Factors with Etiology, Epidemiology of Breast Cancer

Author(s)
Shumla Qasim Faculty of Eastern Medicine, Hamdard University, Pakistan
Rukhsana Rubeen Dow Dental College, Dow University of Health Sciences Karachi, Pakistan
Muhammad Akhlaq Department of ORIC, Hamdard University Karachi, Pakistan
Syeda Alishba Human Nutrition and Dietetics, Faculty of Eastern Medicine, Hamdard University, Pakistan
Elaf Shaikh Human Nutrition and Dietetics, Faculty of Eastern Medicine, Hamdard University, Pakistan
Syed Rizwan Human Nutrition and Dietetics, Faculty of Eastern Medicine, Hamdard University, Pakistan
Abstract
Breast cancer is the most common cancer amongst the girls. It is expected that 2.3 million new instances of BC are recognized globally every year. Based on mRNA gene expression levels, BC may be divided into molecular subtypes that offer insights into new remedy techniques and affected person stratifications that effect the control of BC sufferers. This evaluate addresses the evaluation at the BC epidemiology, danger elements, class with an emphasis on molecular types, prognostic biomarkers, in addition to feasible remedy modalities. Breast most cancers (BC) is the maximum often recognized most cancers in girls international with greater than 2 million new instances in 2020. Its occurrence and loss of life prices have multiplied over the last 3 a long time because of the alternate in danger aspect profiles, higher most cancers registration, and most cancers detection. The range of danger elements of BC is good sized and consists of each the modifiable elements and nonmodifiable elements. Currently, approximately 80% of sufferers with BC are people aged >50. Survival relies upon on each level and molecular subtype. Invasive BCs contain huge spectrum tumors that display a version regarding their scientific presentation, behavior, and morphology. Based on mRNA gene expression levels, BC may be divided into molecular subtypes (Luminal A, Luminal B, HER2-enriched, and basal-like). The molecular subtypes offer insights into new remedy techniques and affected person stratifications that effect the control of BC sufferers. The 8th edition of TNM class outlines a brand new staging device for BC that, similarly to anatomical features, recognizes organic elements. Treatment of breast most cancers is complicated and includes a mixture of exclusive modalities along with surgery, radiotherapy, chemotherapy, hormonal therapy, or organic remedies brought in various sequences.
Publication Details
Page(s) 450-466
DOI DOI not available
Published Journal: Bioscience Research, Volume: 21, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Epidemiology, Radiotherapy, Chemotherapy, Breast Cancer, mRNA gene expression, organic remedies
References
Al-Naggar R. A.,Anil S. .2016 .Artificial light at night and cancer: global study. Asian Pacific Journal of Cancer Prevention: APJCP, 17(10) : 4661.
Albrektsen G.,Heuch I.,Hansen S.,Kvåle G. .2005 .Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. British Journal of Cancer, 92(1) : 167-175.
Ali A. A. L.,Saada H.,Hasan G. A. L.,Quobaili F. A. L. .2021 .Hormone Therapy of Breast cancer (LHRH Agonist). , : .
Angeli D.,Salvi S.,Tedaldi G. .2020 .Genetic predisposition to breast and ovarian cancers: how many and which genes to test?. International Journal of Molecular Sciences, 21(3) : 1128.
Vostakolaei Asadzadeh,Karim-Kos F.,JanssenHeijnen H. E.,Visser M. L. G.,Verbeek O.,Kiemeney A. L. M.,L. A. L. M. A. L. M. .2011 .The validity of the mortality to incidence ratio as a proxy for sitespecific cancer survival. The European Journal of Public Health, 21(5) : 573-577.
Barber M. D.,Thomas J.,Dixon M. .2008 .Breast cancer: an atlas of investigation and management. Clinical Publishing., : .
Bernstein L. .2002 .Epidemiology of endocrine-related risk factors for breast cancer. Journal of Mammary Gland Biology and Neoplasia, 7(1) : 3-15.
Bernstein L.,Ross R. K. .1993 .Endogenous hormones and breast cancer risk. Epidemiologic Reviews, 15(1) : 48-65.
Bird A. .2007 .Perceptions of epigenetics. Nature, 447(7143) : 396.
Bjarnadottir O.,Romero Q.,Bendahl Q.,Jirström K.,Rydén L.,Loman N.,Uhlén M.,Johannesson H.,Rose C.,Grabau D. .2013 .Targeting HMGCoA reductase with statins in a window-ofopportunity breast cancer trial. Breast Cancer Research and Treatment, 138(2) : 499-508.
Bradbury A. R.,Olopade O. I. .2007 .Genetic susceptibility to breast cancer. Reviews in Endocrine and Metabolic Disorders, 8(3) : 255-267.
Brandes L. J.,Arron R. J.,Bogdanovic R. P.,Tong J.,Zaborniak C. L. F.,Hogg G. R.,Warrington R. C.,Fang W.,LaBella F. S. .1992 .Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Research, 52(13) : 3796-3800.
Brewer H. R.,Jones M. E.,Schoemaker M. J.,Ashworth A.,Swerdlow A. J. .2017 .Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Research and Treatment, 165(1) : 193-200.
Buerger H.,Simon R.,Schäfer K. L.,Diallo R.,Littmann R.,Poremba C.,Van Diest P. J.,Dockhorn-Dworniczak B.,Böcker W. .2000 .Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Molecular Pathology, 53(3) : 118.
Calkins G. N.,Fischer Gustav .1914 .By Th. Science, 40(1041) : 857-859.
Cancer B .2001 .Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. The Lancet, 358(9291) : 1389-1399.
Cantor S. B.,Guillemette S. .2011 .Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. , 7(2) : 253-261.
Casey S. C.,Vaccari M.,Al-Mulla F.,Al-Temaimi R.,Amedei A.,Barcellos-Hoff M. H.,Brown M. H.,Chapellier M.,Christopher J.,Curran C. S. .2015 .The effect of environmental chemicals on the tumor microenvironment. Carcinogenesis, 36(Suppl_1) : S160-S183.
Castello A.,Pollán M.,Buijsse B.,Ruiz A.,Casas A. M.,Baena-Cañada J. M.,Lope V.,Antolín S.,Ramos M.,Muñoz M. .2014 .Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study. British Journal of Cancer, 111(7) : 1454-1462.
Catsburg C.,Miller A. B.,Rohan T. E. .2015 .Active cigarette smoking and risk of breast cancer. International Journal of Cancer, 136(9) : 2204-2209.
Çelik A.,Acar M.,Erkul M. C.,Gunduz E.,Gunduz M. .2015 .Relationship of breast cancer with ovarian cancer. Concise Rev. Mol. Pathol. Breast Cancer, : 87-202.
Checka C. M.,Chun J. E.,Schnabel F. R.,Lee J.,Toth H. .2012 .The relationship of mammographic density and age: implications for breast cancer screening. American Journal of Roentgenology, 198(3) : W292-W295.
Chen B.-F.,Suen Y.-K.,Gu S.,Li L.,Chan L. .2014 .A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor. Scientific Reports, 4(1) : 1-8.
Chen C.,Sun L.,Anderson B. O. .2006 .Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the US. Cancer, 107(7) : 1448-1458.
Chen J.,Lindblom A. .2000 .Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p. Clinical Genetics, 57(5) : 394-397.
Chen S.,Chen H.,Yi Y.,Jiang X.,Lei H.,Luo X.,Chen Y.,Liu S.,Yuan D.,Jia X. .2019 .Comparative study of breast cancer with or without concomitant Paget disease: an analysis of the SEER database. Cancer Medicine, 8(8) : 4043-4054.
Chen X.,Wang Q.,Xie Y.,Tan Q.,X. Q. .2019 .Physical activity and risk of breast cancer: a meta-analysis of 38 cohort studies in 45 study reports. Value in Health, 22(1) : 104-128.
Coogan P. F.,Rao S. R.,Rosenberg L.,Palmer J. R.,Strom B. L.,Zauber A. G.,Stolley P. D.,Shapiro S. .1999 .The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Preventive Medicine, 29(2) : 72-76.
Corso G.,Intra M.,Trentin C.,Veronesi P.,Galimberti V. .2016 .CDH1 germline mutations and hereditary lobular breast cancer. Familial Cancer, 15(2) : 215-219.
Corso G.,Veronesi P.,Sacchini V.,Galimberti V. .2018 .Prognosis and outcome in CDH1-mutant lobular breast cancer. , : .
Cui Y.,Rohan T. E. .2006 .Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiology and Prevention Biomarkers, 15(8) : 1427-1437.
Daly M. B.,Pal T.,Berry M. P.,Buys S. S.,Dickson P.,Domchek S. M.,Elkhanany A.,Friedman S.,Goggins M.,Hutton M. L. .2021 .NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 19(1) : 77-102.
Dandamudi A.,Tommie J.,Nommsen-Rivers L.,Couch S. .2018 .Dietary patterns and breast cancer risk: a systematic review. Anticancer Research, 38(6) : 3209-3222.
DeSantis C. E.,Fedewa S. A.,Goding Sauer,Kramer A.,Smith J. L.,Jemal R. A.,A. R. A. .2015 .: Convergence of incidence rates between black and white women. CA: A Cancer Journal for Clinicians, 66(1) : 31-42.
Duffy S. W.,Morrish O. W. E.,Allgood P. C.,Black R.,Gillan M. G. C.,Willsher P.,Cooke J.,Duncan K. A.,Michell M. J.,Dobson H. M. .2018 .Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer. European Journal of Cancer, 88 : 48-56.
Dyrstad S. W.,Yan Y.,Fowler A. M.,Colditz G. A. .2015 .Breast cancer risk associated with benign breast disease: systematic review and metaanalysis. Breast Cancer Research and Treatment, 149(3) : 569-575.
Eichbaum C.,Wang N.,Bischofs E.,Steinborn A.,Bruckner T.,Brodt P.,Sohn C.,Eichbaum M. H. R. .2011 .Breast cancer cellderived cytokines, macrophages and cell adhesion: implications for metastasis. Anticancer Research, 31(10) : 3219-3227.
El-Sharkawy A.,Malki A. .2020 .Vitamin D signaling in inflammation and cancer: Molecular mechanisms and therapeutic implications. Molecules, 25(14) : 3219.
Endo Y.,Yamashita H.,Takahashi S.,Sato S.,Yoshimoto N.,Asano T.,Hato Y.,Dong Y.,Fujii Y.,Toyama T. .2014 .Immunohistochemical determination of the miR-1290 target arylamine Nacetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. Bmc Cancer, 14(1) : 1-9.
Erol A.,Ho A. M.,Winham S. J.,Karpyak V. M. .2019 .Sex hormones in alcohol consumption: a systematic review of evidence. Addiction Biology, 24(2) : 157-169.
Estébanez N.,Gómez-Acebo I.,Palazuelos C.,Llorca J.,Dierssen-Sotos T. .2018 .Vitamin D exposure and Risk of Breast Cancer: a metaanalysis. Scientific Reports, 8(1) : 1-13.
Eve L.,Fervers B.,Le Romancer M.,EtienneSelloum N. .2020 .Exposure to endocrine disrupting chemicals and risk of breast cancer. International Journal of Molecular Sciences, 21(23) : 9139.
Feuer E. J. .1997 .. Stat Bite: Lifetime Probability of Cancer, : .
Fiolet T.,Srour B.,Sellem L.,Kesse-Guyot E.,Allès B.,Méjean C.,Deschasaux M.,Fassier P.,Latino-Martel P.,Beslay M. .2018 .Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort. Bmj, 360 : .
Folkerd E.,Dowsett M. .2013 .Sex hormones and breast cancer risk and prognosis. The Breast, 22 : S38-S43.
Foretová L.,Navrátilová M.,Svoboda M.,Vašíčková P.,Sťahlová E. H.,Házová J.,Kleiblová P.,Kleibl Z.,Macháčková E.,Palácová M. .2019 .Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti, 32(Supplementum2) : 6-13.
Forman D.,Bray F.,Brewster D. H.,Mbalawa Gombe,Kohler C.,Piñeros B.,Steliarova-Foucher M.,Swaminathan E.,Ferlay R.,J. R. .2013 .Cancer incidence in five continents. Vol. X. IARC Scientific Publication, 164 : .
Friedman G. D.,Oestreicher N.,Chan J.,Quesenberry C. P.,Udaltsova N.,Habel L. A. .2006 .Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiology and Prevention Biomarkers, 15(11) : 2102-2106.
Fusco N.,Sajjadi E.,Venetis K.,Gaudioso G.,Lopez G.,Corti C.,Guerini Rocco E.,Criscitiello C.,Malapelle U.,Invernizzi M. .2020 .PTEN alterations and their role in cancer management: are we making headway on precision medicine?. Genes, 11(7) : 719.
Gerin I.,Bommer G. T.,McCoin C. S.,Sousa K. M.,Krishnan V.,MacDougald O. A. .2010 .Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. American Journal of PhysiologyEndocrinology and Metabolism, 299(2) : E198-E206.
Ginsburg O.,Bray F.,Coleman M. P.,Vanderpuye V.,Eniu A.,Kotha S. R.,Sarker M.,Huong M.,Allemani C.,Dvaladze A. .2017 .The global burden of women's cancers: a grand challenge in global health. The Lancet, 389(10071) : 847-860.
Giordano S. H. .2018 .Breast cancer in men. New England Journal of Medicine, 378(24) : 2311-2320.
Group E. H.,B. C. C. E. H. .2002 .Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute, 94(8) : 606-616.
Hall J. M.,Lee M. K.,Newman B.,Morrow J. E.,Anderson L. A.,Huey B.,King M.-C. .1990 .Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250(4988) : 1684-1689.
Harn H.,Shen K. L.,Yueh K. C.,Ho L. I.,Yu J. C.,Chiu S. C.,Lee W. H. .1997 .Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal‐deoxynucleotidyl‐transferasemediated dUTP‐FITC nick end labelling (TUNEL. , 31(6) : 534-539.
Heitzer E.,Lax S.,Lafer I.,Müller S. M.,Pristauz G.,Ulz P.,Jahn S.,Högenauer C.,Petru E.,Speicher M. R. .2013 .Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1in a patient with bilateral breast and endometrial adenocarcinoma. BMC Medical Genetics, 14(1) : 1-6.
Hilakivi-Clarke L. .2014 .Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Research, 16(2) : 1-10.
Hoffman-Goetz L. .1998 .Influence of physical activity and exercise on innate immunity. Nutrition Reviews, 56(1) : S126.
Hoover R. N.,Hyer M.,Pfeiffer R. M.,Adam E.,Bond B.,Cheville A. L.,Colton T.,Hartge P.,Hatch E. E.,Herbst A. L. .2011 .Adverse health outcomes in women exposed in utero to diethylstilbestrol. New England Journal of Medicine, 365(14) : 1304-1314.
Hopper J. L.,Dite G. S.,Liao MacInnis,Zeinomar Y.,Knight N.,Southey J. A.,Milne M. C.,Chung R. L.,Giles W. K.,G. G. W. K. .2018 .Agespecific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProFSC). Breast Cancer Research, 20(1) : 1-11.
Hormones E.,B. C. C. E. .2013 .Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. The Lancet Oncology, 14(10) : 1009-1019.
Hoskins L. M.,Roy K.,Peters J. A.,Loud J. T.,Greene M. H. .2008 .Disclosure of positive BRCA1/2-mutation status in young couples: The journey from uncertainty to bonding through partner support. Families, 26(3) : 296.
Hu Z.-Y.,Liu L.,Xie N.,Lu J.,Liu Z.,Tang Y.,Wang Y.,Yang J.,Ouyang Q. .2020 .Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers. , 829 : .
Husby A.,Wohlfahrt J.,Øyen N.,Melbye M. .2018 .Pregnancy duration and breast cancer risk. Nature Communications, 9(1) : 1-7.
Huss L.,Butt S. T.,Borgquist S.,Elebro K.,Sandsveden M.,Rosendahl A.,Manjer J. .2019 .Vitamin D receptor expression in invasive breast tumors and breast cancer survival. Breast Cancer Research, 21(1) : 1-13.
Innes K. E.,Byers T. E. .1999 .Preeclampsia and breast cancer risk. Epidemiology, 722 : 732.
Iyengar N. M.,Arthur R.,Manson J. E.,Chlebowski J. E.,Kroenke C. H.,Peterson C. H.,Feliciano E. C.,Lane D.,Luo J. .2019 .Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study. JAMA Oncology, 5(2) : 155-163.
Jamali F. R.,Ricci Jr,Deckers A.,P. J. A. .1996 .Paget's disease of the nipple-areola complex. Surgical Clinics of North America, 76(2) : 365-381.
James F. R.,Wootton S.,Jackson A.,Wiseman M.,Copson E. R.,Cutress R. I. .2015 .Obesity in breast cancer-what is the risk factor?. European Journal of Cancer, 51(6) : 705-720.
Joerger M.,Baty F.,Früh M.,Droege C.,Stahel R. A.,Betticher D. C.,von Moos,Ochsenbein R.,Pless A.,Gautschi M.,O. M. .2014 .Circulating microRNA profiling in patients with advanced nonsquamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression. Lung Cancer, 85(2) : 306-313.
Johns L. E.,Jones M. E.,Schoemaker M. J.,McFadden E.,Ashworth A.,Swerdlow A. J. .2018 .Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study. British Journal of Cancer, 118(4) : 600-606.
Jung M.,Mollenkopf H.,Grimm C.,Wagner I.,Albrecht M.,Waller T.,Pilarsky C.,Johannsen M.,Stephan C.,Lehrach H. .2009 .MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. Journal of Cellular and Molecular Medicine, 13(9b) : 3918-3928.
Kamel G. S.,Salman S. M.,Abood W. N. .2019 .Evaluation of P53 and Some Blood Parameters In Women Diagnosed With Breast Cancer. Diyala Journal of Medicine, 17(1) : 9-15.
Kechagioglou P.,Papi R. M.,Provatopoulou X.,Kalogera E.,Papadimitriou E.,Grigoropoulos P.,Nonni A.,Zografos G.,Kyriakidis D. A.,Gounaris A. .2014 .Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression. Anticancer Research, 34(3) : 1387-1400.
Kim B.-C.,Jeong H. O.,Park D.,Kim C.-H.,Lee E. K.,Kim D. H.,Im E.,Kim N. D.,Lee S.,Yu B. P.,CIN-S16912. B. P. .2015 .Cancer Informatics: Profiling AgeRelated Epigenetic Markers of Stomach Adenocarcinoma in Young and Old Subjects. Cancer Informatics, 14 : .
Kim E. Y.,Chang Y.,Ahn J.,Yun J.,Park Y. L.,Park C. H.,Shin H.,Ryu S. .2020 .Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women. Cancer, 126(21) : 4687-4696.
Kim G.,An G.,Lee M.,Song M.,Jeong M.,Lee J.-H.,Jeong H.-C. .2016 .Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. Lung Cancer, 91 : 15-22.
Kim S. K.,Won Y. H.,Kim S.-J. .2014 .Nipple eczema: a diagnostic challenge of allergic contact dermatitis. Annals of Dermatology, 26(3) : 413-414.
Kluźniak W.,Wokołorczyk D.,Rusak B.,Huzarski T.,Gronwald J.,Stempa K.,Rudnicka H.,Kashyap A.,Dębniak T.,Jakubowska A. .2019 .Inherited variants in XRCC2 and the risk of breast cancer. Breast Cancer Research and Treatment, 178(3) : 657-663.
Kolb R.,Zhang W. .2020 .Obesity and breast cancer: a case of inflamed adipose tissue. Cancers, 12(6) : 1686.
Korkaya H.,Wicha S.,M. S. S. .2011 .Breast cancer stem cells, cytokine networks, and the tumor microenvironment. The Journal of Clinical Investigation, 121(10) : 3804-3809.
Lawlor D. A.,Jüni P.,Ebrahim S.,Egger M. .2003 .Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer. Journal of Clinical Epidemiology, 56(2) : 155-163.
Leong P. W.,Chotai N. C.,Kulkarni S. .2018 .Imaging features of inflammatory breast disorders: a pictorial essay. Korean Journal of Radiology, 19(1) : 5-14.
Leso V.,Ercolano M. L.,Cioffi D. L.,Iavicoli I. .1882 .Occupational chemical exposure and breast cancer risk according to hormone receptor status: a systematic review. Cancers, 11(12) : .
Li M.,Yin Y.-C.,Wang J.,Jiang Y.-F. .2014 .Green tea compounds in breast cancer prevention and treatment. World Journal of Clinical Oncology, 5(3) : 520.
Li X.,Wu Z.,Ni J.,Meng Y.,Yu J.,Nakanishi W.,Zhou H.,Y. H. .2016 .Cathepsin B regulates collagen expression by fibroblasts via prolonging TLR2/NF-κB activation. Oxidative Medicine and Cellular Longevity, : .
Liu D.,Chen Z. .2013 .The effect of curcumin on breast cancer cells. Journal of Breast Cancer, 16(2) : 133-137.
Liu Y.,Nguyen N.,Colditz G. A. .2015 .Links between alcohol consumption and breast cancer: a look at the evidence. Women's Health, 11(1) : 65-77.
Łukasiewicz S.,Czeczelewski M.,Forma A.,Baj J.,Sitarz R.,Stanisławek A.,Cancer-Epidemiology A. .2021 .Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. , 13(17) : 4287.
Lyons K. E.,Ryan C. A.,Dempsey E. M.,Ross R. P.,Stanton C. .2020 .Breast milk, a source of beneficial microbes and associated benefits for infant health. Nutrients, 12(4) : 1039.
Maass N.,Biallek M.,Rösel F.,Schem C.,Ohike N.,Zhang M.,Jonat W.,Nagasaki K. .2002 .Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochemical and Biophysical Research Communications, 297(1) : 125-128.
Marcotte R.,Brown K. R.,Suarez F.,Sayad A.,Karamboulas K.,Krzyzanowski P. M.,Sircoulomb F.,Medrano M.,Fedyshyn Y.,Koh J. L. Y. .2012 .Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discovery, 2(2) : 172-189.
McGuire A.,Brown J. A. L.,Malone C.,McLaughlin R.,Kerin M. J. .2015 .Effects of age on the detection and management of breast cancer. Cancers, 7(2) : 908-929.
Mehrgou A.,Akouchekian M. .2016 .The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Medical Journal of the Islamic Republic of Iran, 30 : 369.
Meijers-Heijboer ,Klijn J.,Wasielewski J.,de Snoo A.,Oldenburg R.,Hollestelle A.,Houben M.,Crepin E.,Veghel-Plandsoen M. .2002 .Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genetics, 31(1) : .
Misotti A. M.,Gnagnarella P. .2013 .Vitamin supplement consumption and breast cancer risk: a review. Ecancermedicalscience, 7 : .
Ng J.,Shuryak I. .2015 .Minimizing second cancer risk following radiotherapy: current perspectives. Cancer Management and Research, 7 : 1.
Ogata Y.,Matsui S.,Kato A.,Zhou L.,Nakayama Y.,Takai H. .2014 .MicroRNA expression in inflamed and noninflamed gingival tissues from Japanese patients. Journal of Oral Science, 56(4) : 253-260.
Olsen J. H.,Sørensen H. T.,Friis S.,McLaughlin J. K.,Steffensen F. H.,Nielsen G. L.,Andersen M.,Fraumeni Jr,Olsen J. F.,J. J. F. .1997 .Cancer risk in users of calcium channel blockers. Hypertension, 29(5) : 1091-1094.
Orgéas C. C.,Hall P.,Rosenberg L. U.,Czene K. .2008 .The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer. Breast Cancer Research, 10(6) : 1-9.
Pahor M.,Guralnik J. M.,Salive M. E.,Corti C.,Carbonin P.,Havlik R. J. .1996 .Do calcium channel blockers increase the risk of cancer?. American Journal of Hypertension, 9(7) : 695-699.
Palmer J. R.,Wise L. A.,Hatch E. E.,Troisi R.,Strohsnitter L.,Herbst W.,Noller A. L.,Hyer K. L.,M. K. L. .2006 .Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiology and Prevention Biomarkers, 15(8) : 1509-1514.
Pandey P.,Yadav S.,Pandey R.,Mishra M. K. .2021 .Gold nanoparticles as a potential treatment for breast cancer: a review. AJPTI, 9(2) : 21-28.
Park D. J.,Lesueur F.,Nguyen-Dumont T.,Pertesi M.,Odefrey F.,Hammet F.,Neuhausen S. L.,John E. M.,Andrulis I. L.,Terry M. B. .2012 .Rare mutations in XRCC2 increase the risk of breast cancer. The American Journal of Human Genetics, 90(4) : 734-739.
Parkin D. .1992 .Cancer incidence in five continents. IARC Sci. Publ., 6, : 960-961.
Poole A. J.,Li Y.,Kim Y.,Lin S.-C. J.,Lee W.-H.,Lee E. Y.-H. .2006 .Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science, 314(5804) : 1467-1470.
Protani M.,Coory M.,Martin J. H. .2010 .Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Research and Treatment, 123(3) : 627-635.
Protopsaltis I.,Drossou A.,Katsantonis I.,Roussos N.,Manoludaki K.,Arvanitis M.,Papazafiropoulou A.,Antonopoulos S. .2014 .Breast cancer presenting as paraneoplastic erythroderma: an extremely rare case. Case Reports in Medicine, : .
Rahman N.,Seal S.,Thompson D.,Kelly P.,Renwick A.,Elliott A.,Reid S.,Spanova K.,Barfoot R.,Chagtai T. .2007 .PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature Genetics, 39(2) : 165-167.
Rainville I.,Hatcher S.,Rosenthal E.,Larson K.,Bernhisel R.,Meek S.,Gorringe H.,Mundt E.,Manley S. .2020 .High risk of breast cancer in women with biallelic pathogenic variants in CHEK2. Breast Cancer Research and Treatment, 180(2) : 503-509.
Rajagopalan H.,Lengauer C. .2004 .Aneuploidy and cancer. Nature, 432(7015) : 338-341.
Rees G.,Fry A.,Cull A. .2001 .A family history of breast cancer: women's experiences from a theoretical perspective. Social Science & Medicine, 52(9) : 1433-1440.
Reeves G. K.,Kan S.,Key T.,Tjønneland A.,Olsen A.,Overvad K.,Peeters P. H.,Clavel‐Chapelon F.,Paoletti X.,Berrino F. .2006 .Breast cancer risk in relation to abortion: Results from the EPIC study. International Journal of Cancer, 119(7) : 1741-1745.
Renwick A.,Thompson D.,Seal S.,Kelly P.,Chagtai T.,Ahmed M.,North B.,Jayatilake H.,Barfoot R.,Spanova K. .2006 .ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nature Genetics, 38(8) : 873-875.
Robinson G. W.,Karpf A. B.,Kratochwil K. .1999 .Regulation of mammary gland development by tissue interaction. Journal of Mammary Gland Biology and Neoplasia, 4(1) : 9-19.
Rodgers K. M.,Udesky J. O.,Rudel R. A.,Brody J. G. .2018 .Environmental chemicals and breast cancer: an updated review of epidemiological literature informed by biological mechanisms. Environmental Research, 160 : 152-182.
Rogol A. D.,Roemmich J. N.,Clark P. A. .2002 .Growth at puberty. Journal of Adolescent Health, 31(6) : 192-200.
Ross J. S.,Fletcher J. A.,Linette G. P.,Stec J.,Clark E.,Ayers M.,Symmans W. F.,Pusztai L.,Bloom K. J. .2003 .The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. The Oncologist, 8(4) : 307-325.
Salomon J. A. .2010 .New disability weights for the global burden of disease. In Bulletin of the World Health Organization, 88 : 879.
Sankaranarayanan R.,Swaminathan R.,Brenner H.,Chen K.,Chia K. S.,Chen J. G.,Law S. C. K.,Ahn Y.-O.,Xiang Y. B.,Yeole B. B. .2010 .Cancer survival in Africa, Asia, and Central America: a population-based study. The Lancet Oncology, 11(2) : 165-173.
Schacht D. V,Yamaguchi K.,Lai J.,Kulkarni K.,Sennett C. A.,Abe H. .2014 .Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. American Journal of Roentgenology, 202(2) : 289-292.
Seal S.,Thompson D.,Renwick A.,Elliott A.,Kelly P.,Barfoot R.,Chagtai T.,Jayatilake H.,Ahmed M.,Spanova K. .2006 .Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nature Genetics, 38(11) : 1239-1241.
Shahbandi A.,Nguyen H. D.,,Jackson J. G. .2020 .TP53 mutations and outcomes in breast cancer: reading beyond the headlines. Trends in Cancer, 6(2) : 98-110.
Sharma G. N.,Dave R.,Sanadya J.,Sharma P.,Sharma K. K. .2010 .Various types and management of breast cancer: an overview. Journal of Advanced Pharmaceutical Technology & Research, 1(2) : 109.
Sharma R. .2021 .Breast Cancer Research. , 187(2) : 557-567.
Shiovitz S.,Korde L. A. .2015 .Genetics of breast cancer: a topic in evolution. Annals of Oncology, 26(7) : 1291-1299.
Shiyanbola O. O.,Arao R. F.,Miglioretti D. L.,Sprague B. L.,Hampton J. M.,Stout N. K.,Kerlikowske K.,Braithwaite D.,Buist D. S. M.,Egan K. M. .2017 .Emerging trends in family history of breast cancer and associated risk. Cancer Epidemiology and Prevention Biomarkers, 26(12) : 1753-1760.
Society A. C. .2014 .American Cancer Society. , : .
Steingart A.,Cotterchio M.,Kreiger N.,Sloan M. .2003 .Antidepressant medication use and breast cancer risk: a case-control study. International Journal of Epidemiology, 32(6) : 961-966.
Stuebe A. .2009 .The risks of not breastfeeding for mothers and infants. Reviews in Obstetrics and Gynecology, 2(4) : 222.
Sun C.,Sang M.,Li S.,Sun X.,Yang C.,Xi Y.,Wang L.,Zhang F.,Bi Y.,Fu Y. .2015 .HsamiR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of cMet. Oncotarget, 6(37) : 39756.
Sun L.,Zhu Y.,Qian Q.,Tang L. .2018 .Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis. Medicine, 97(26) : .
Teixeira M. R.,Pandis N.,Gerdes A.-M.,Dietrich C. U.,Bardi G.,Andersen J. A.,Graversen H. P.,Mitelman F.,Heim S. .1996 .Cytogenetic abnormalities in anin situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer. Breast Cancer Research and Treatment, 38(2) : 177-182.
Terry P. D.,Rohan T. E. .2002 .Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiology and Prevention Biomarkers, 11(10) : 953-971.
Thompson D.,Easton D. F. .2002 .Cancer incidence in BRCA1 mutation carriers. Journal of the National Cancer Institute, 94(18) : 1358-1365.
Ursin G.,Bernstein L.,Lord S. J.,Karim R.,Deapen D.,Daling M. F.,Norman J. R.,Liff S. A.,Marchbanks J. M.,P. A. J. M. .2005 .Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. British Journal of Cancer, 93(3) : 364-371.
Velicer C. M.,Lampe J. W.,Heckbert S. R.,Potter J. D.,Taplin S. H. .2003 .Hypothesis: is antibiotic use associated with breast cancer? Cancer Causes. , 14(8) : 739-747.
Videnros C.,Selander J.,Wiebert P.,Albin M.,Plato N.,Borgquist S.,Manjer J.,Gustavsson P. .2020 .Investigating the risk of breast cancer among women exposed to chemicals: A nested case-control study using improved exposure estimates. International Archives of Occupational and Environmental Health, 93(2) : 261-269.
Vinogradova Y.,Coupland C.,Hippisley-Cox J. .2020 .Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. Bmj, 371 : .
Wang J.,Costantino J. P.,Tan-Chiu E.,Wickerham D. L.,Paik S.,Wolmark N. .2004 .Lower-category benign breast disease and the risk of invasive breast cancer. Journal of the National Cancer Institute, 96(8) : 616-620.
Wang X.,Hui X.,Wang M.-Q.,Liu H.,Li H.,Song Z.-C. .2019 .Body mass index at diagnosis as a prognostic factor for early-stage invasive breast cancer after surgical resection. Oncology Research and Treatment, 42(4) : 190-196.
Welcsh P. L.,King M.-C. .2001 .BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Human Molecular Genetics, 10(7) : 705-713.
Wu ,Do C.,Andrulis I. L.,John E. M.,Daly M. B.,Buys S. S.,Chung W. K.,Knight J. A.,Bradbury A. R.,Keegan T. H. M. .2018 .Breast cancer family history and allele-specific DNA methylation in the legacy girls study. Epigenetics, 13(3) : 240-250.
Zeinomar N.,Knight J. A.,Genkinger J. M.,Phillips K.,Daly M. B.,Milne R. L.,Dite G. S.,Kehm R. D.,Liao Y.,Southey M. C. .2019 .Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC). Breast Cancer Research, 21(1) : 1-14.
Zhang Q.,Liu J.,Ao N.,Yu H.,Peng Y.,Ou L.,Zhang S. .2020 .Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques. Scientific Reports, 10(1) : 1-12.
Zhou L.,Chen B.,Sheng L.,Turner A. .2020 .The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis. Breast Cancer Research and Treatment, 182(1) : 1-8.
0

Citations

0

Downloads

74

Views